<?xml version='1.0' encoding='utf-8'?>
<document id="31746843"><sentence text="3D spheroids generated on carbon nanotube-functionalized fibrous scaffolds for drug metabolism and toxicity screening."><entity charOffset="26-32" id="DDI-PubMed.31746843.s1.e0" text="carbon" /></sentence><sentence text="The mechanical and electrical stimuli have a profound effect on the cellular behavior and function" /><sentence text=" In this study, a series of conductive nanofibrous scaffolds are developed by blend electrospinning of poly(styrene-co-maleic acid) (PSMA) and multiwalled-carbon nanotubes (CNTs), followed by grafting galactose as cell adhesion cues"><entity charOffset="155-161" id="DDI-PubMed.31746843.s3.e0" text="carbon" /><entity charOffset="201-210" id="DDI-PubMed.31746843.s3.e1" text="galactose" /><pair ddi="false" e1="DDI-PubMed.31746843.s3.e0" e2="DDI-PubMed.31746843.s3.e0" /><pair ddi="false" e1="DDI-PubMed.31746843.s3.e0" e2="DDI-PubMed.31746843.s3.e1" /></sentence><sentence text=" When the mass ratios of CNTs to PSMA increase up to 5%, the alignment, Young's modulus and conductivity of fibrous scaffolds increase, whereas the average diameter, pore size and elongation at break decrease" /><sentence text=" Primary hepatocytes cultured on the scaffolds are self-assembled into 3D spheroids, which restores the hepatocyte polarity and sufficient expression of drug metabolism enzymes over an extended period of time" /><sentence text=" Among these conductive scaffolds, hepatocytes cultured on fibers containing 3% of CNTs (F3) show the highest clearance rates of model drugs, offering a better prediction of the in vivo data with a high correlation value" /><sentence text=" Moreover, the drug metabolism capability is maintained over 15 days and is more sensitive towards the inducers and inhibitors of metabolizing enzymes, demonstrating the applicability for drug-drug interaction studies" /><sentence text=" Thus, this culture system has been demonstrated as a reliable in vitro model for high-throughput screening of metabolism and toxicity in the early phases of drug development" /><sentence text="" /></document>